NCT04430842 2023-01-18
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Quadriga Biosciences, Inc.
Phase 1 Completed
Quadriga Biosciences, Inc.
Children's Memorial Health Institute, Poland
Medical College of Wisconsin
Ziekenhuis Oost-Limburg